Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Myelofibrosis
Interventions
DRUG

Ruxolitinib

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER

NCT05410470 - Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis | Biotech Hunter | Biotech Hunter